Area of research
Endocrinology, Diabetes and Metabolism · Genetics
Research interest
Research interests include Cancer research, Biology, Thyroid cancer, Medicine, Thyroid, and HRAS.
Association of Treatment Strategies and Tumor Characteristics With Overall Survival Among Patients With Anaplastic Thyroid Cancer
Supplementary Figures 1-11 from Proto-oncogene PBF/PTTG1IP Regulates Thyroid Cell Growth and Represses Radioiodide Treatment
Supplementary Figures 1-11 from Proto-oncogene PBF/PTTG1IP Regulates Thyroid Cell Growth and Represses Radioiodide Treatment
SWI/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation Therapies
Vemurafenib Redifferentiation of <i>BRAF</i> Mutant, RAI-Refractory Thyroid Cancers
<i>EIF1AX</i> and <i>RAS</i> Mutations Cooperate to Drive Thyroid Tumorigenesis through ATF4 and c-MYC
Tipifarnib Inhibits HRAS-Driven Dedifferentiated Thyroid Cancers
Hgf/Met activation mediates resistance to BRAF inhibition in murine anaplastic thyroid cancers
Oncogene-induced senescence and its evasion in a mouse model of thyroid neoplasia
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
<i>NF2</i> Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition
Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers
STAT3 negatively regulates thyroid tumorigenesis